Absolute Eosinophil Counts and Colonic Mucosal Eosinophils Based on Inflammatory Bowel Disease Severity

https://doi.org/10.22146/actainterna.98159

Nisma Aulia(1*), Deshinta Putri Mulya(2), Putut Bayupurnama(3)

(1) Internal Medicine Specialist Program, Department of Internal Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital
(2) Internal Medicine Specialist Program, Department of Internal Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital
(3) Division of Gastroenterohepatology, Department of Internal Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito General Hospital
(*) Corresponding Author

Abstract


Background. The inflammatory process in Inflammatory Bowel Disease (IBD) involves various types of inflammatory cells, including eosinophils. Eosinophils are not only associated with the severity of IBD but are also associated with clinical improvement. In contrast to the confirmed role of neutrophils, the role of eosinophils either in the blood or in the colonic mucosa of IBD patients have not been fully understood and confirmed.

Objectives. To determine the difference in absolute eosinophil counts in the blood based on the severity of IBD and to determine the differences in the density of colonic mucosal eosinophil based on the severity of IBD.

Methods. This is a cross-sectional study with consecutive sampling in the period August 2020 - July 2021. The research subjects were IBD inpatient or outpatient at Dr. Sardjito Hospital who met the inclusion and exclusion criteria. Researcher assessed data on absolute eosinophil counts in peripheral blood and eosinophil density in the colonic mucosa. The number of biopsies and the location of the biopsy were determined based on a colonoscopy performed by a Gastroentero-Hepatology Consultant. The calculation of eosinophils in the colonic mucosal tissue was carried out by an Anatomical Pathologist Specialist. IBD severity was assessed using the Truelove Witts score for Ulcerative Colitis (UC) and Crohn's Disease Activity Index (CDAI) for Crohn's Disease (CD) patients. Analysis using a computer program with a p value <0.05 was considered statistically significant.

Results. There were 50 research subjects with a median age of 55 years (24-77 years). There was not a big difference between the number of male and female patients, namely 26 people (52%) vs 24 people (48%). The number of UC patients were dominant, namely 48 people (96%). The severity of IBD were divided into three groups with the number of patients with mild IBD were 22 (44%), moderate were 11 (20%), and severe IBD were 18 (36%). The number of patients with eosinophilia were 7 patients (14%) and colonic mucosal eosinophilia were 5 patients (10%). Kruskal Wallis test found that the mean absolute eosinophil blood in mild IBD was 21.45 cells/µL, moderate IBD was 25.50 cells/µL, and severe IBD was 30.44 cells/µL (p = 0.152). The mean of colonic mucosal eosinophils in mild IBD was 19.48 cells/hpf, in moderate IBD was 27.00 cells/hpf, in severe IBD was 32.03 cells/hpf (p = 0.023) and there was a statistically significant moderate correlation (r = 0.392; p = 0.005).

Conclusion. There is no significant difference in absolute eosinophil counts in the blood based on the severity of IBD and there is a significant difference in the density of colonic mucosal eosinophil based on the severity of IBD.

Keywords


Inflammatory Bowel Disease (IBD), absolute eosinophil counts, colonic mucosal eosinophils

Full Text:

PDF


References

Fauci A. S., Longo D. L., Jameson L., Kasper D., Hauser S. L. 2012. Inflammatory Bowel disease. Harrison's Principles of Internal Medicine. 8th ed. The Mac-raw Hill Companies, Inc.

Lampinen M., Ronnblom A., Amin K., Kristjansson G., Rorsman F., et al. 2005. Eosinophil granulocytes are activated during the remission phase of ulcerative colitis. gut. 54:1714–1720. doi:10.1136/gut.2005.066423.

Rothenberg M. E & Hogan SP 2006. The Eosinophil. annu. Rev. Immunol. 24:147–74.

Loktinov A. 2019. Eosinophils in the gastrointestinal tract and their role in the pathogenesis of major colorectal disorders. World J Gastroenterol. 25(27): 3503-3526.

Rothenberg ME 2004. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol. 113:11-28.

Al-Haddad S & Riddell RH 2005. The role of eosinophils in inflammatory bowel disease. gut. 54:1674–1675. doi: 10.1136/gut.2005.072595.

Xu, X., Rivkind, A., Pikarsky, A., Pappo, O., Bischoff, SC, & Levi Schaffer , F. , et al. 2004. Mast cells and eosinophils have a potential profibrogenic role in Crohn's disease. Scandinavian Journal of Gastroenterology. 39(5): 440–447. doi: 10.1080/0036552031000856.

Ramirez GA, Yacoub MN, Ripa M., Mannina D., Cariddi A., et al. 2018. Eosinophils from Physiology to Disease: A Comprehensive Review. Hindawi BioMed Research International. https://doi.org/10.1155/2018/9095275.

Mustika S & Triana N, 2016. The Prevalence, Profile, and Risk Factor of Patients with Ulcerative Colitis at Dr. Saiful Anwar Malang General Hospital. The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy. 17(1):16-20.

Hammer T & Langholz E. 2020. The epidemiology of inflammatory bowel disease: balance between East and West? A narrative review. Dig Med Res. 3:48

Click B., Anderson AM, Koutroubakis IE, Rivers CR, Babichenko D., et al. 2017. Peripheral Eosinophilia in Patients with Inflammatory Bowel Disease Defines an Aggressive Disease Phenotype. Am J Gastroenterol. doi:10.1038/ajg.2017.402

Morgensterm S, Brook E, Rinawi F, Shamir R, Assa A. 2016. Tissue and peripheral eosinophilia as predictors for disease outcome in children with ulcerative colitis. Dig Liver Dis. 49(2):170-174.

Prathapan KM, Rivers CR, Anderson A, Koutroumpakis F, Koutroubakis IE, et al. 2020. Peripheral Blood Eosinophilia and Long-term Severity in Pediatric-Onset Inflammatory Bowel Disease. Inflamm Bowel Dis. 26 (12): 1890-1900.

Alhmoud T., Gremida A., Colom Steele D., Fallahi I., Tuqan W., Nandy N., et al. 2020. Outcomes of inflammatory bowel disease in patients with eosinophil-predominant colonic inflammation. BMJ Open Gastro. 7:e000373. doi:10.1136/ bmjgast-2020-000373

Sadi G. , Yang Q., Dufault B., Stefanovici C., Stoffman J., et al. 2016. Prevalence of Peripheral Eosinophilia at Diagnosis in Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 62(4):573-6.

Dharmika S. 2009. Inflammatory bowel disease in Sudoyo AW, Setiyohadi, B (Eds): Textbook of Internal Medicine 5 th edition. InternaPublishing. Jakarta. 591-597

Sarin SK., Malhotra V., Sen Gupta S., Karol A., Gaur SK, et al. 1987. Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study. Dig Dis Sci. 32(4):363-7. doi:10.1007/BF01296289.

Hogan SP, Rosenberg HF, Moqbel R., Phipps S., Foster PS, et al. 2008. Eosinophils: Biological Properties and Role in Health and Disease. Clinical and Experimental Allergy. 38: 709–750

Barrie A., El-Mourabet M., Weyant K., Clarke K., Gajendran M., et al. 2013. Recurrent blood eosinophilia in ulcerative colitis is associated with severe disease and primary sclerosing cholangitis. Dig Dis Sci . 58(1): 222–228



DOI: https://doi.org/10.22146/actainterna.98159

Article Metrics

Abstract views : 26 | views : 3

Refbacks

  • There are currently no refbacks.




Copyright (c) 2024 Acta Interna: The Journal of Internal Medicine

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Acta Interna The Journal of Internal Medicine Indexed by:

 

 Indonesia Onesearch Google Scholar IPI Indonesian Publication Index

 website statistics View My Stats  

 

 

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.